iNCOVACC is to be administered as a booster dose for those above 18 years of age who had previously received two doses of either Covishield or Covaxin. The needleless vaccine for easy, pain-free administration, India's first such booster dose, received the Central Drugs Standard Control Organization (CDSCO) approval for emergency use last month. Who developed iNCOVACC?
1
Serum Institute of India
2
Bharat Biotech
3
Cipla
4
Biocon
5
Lupin